EXT608

· Extend Biosciences Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EXT608, covering 2025-02-04 to 2025-05-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Trial Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults With Hypoparathyroidism [Phase 2]

See pricing